Pathological functions of the small GTPase Arf6 in cancer progression: Tumor angiogenesis and metastasis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26909552)

Published in Small GTPases on February 24, 2016

Authors

Tsunaki Hongu1, Yohei Yamauchi1, Yuji Funakoshi1, Naohiro Katagiri1, Norihiko Ohbayashi1, Yasunori Kanaho1

Author Affiliations

1: a Department of Physiological Chemistry , Faculty of Medicine and Graduate School of Comprehensive Human Sciences, University of Tsukuba , Tsukuba , Japan.

Articles cited by this

Hallmarks of cancer: the next generation. Cell (2011) 140.01

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (1996) 18.47

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (1996) 16.92

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell (2009) 16.06

Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 14.17

Molecular mechanisms and clinical applications of angiogenesis. Nature (2011) 13.36

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell (2009) 13.09

Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol (2001) 10.32

Microenvironmental regulation of tumor progression and metastasis. Nat Med (2013) 8.37

ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol (2006) 7.75

Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell (1999) 4.98

The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol (2011) 4.24

ARF family G proteins and their regulators: roles in membrane transport, development and disease. Nat Rev Mol Cell Biol (2011) 3.38

Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic (2004) 2.91

GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat Cell Biol (2007) 2.88

An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene (1999) 2.86

ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol (2009) 2.82

A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev (2006) 2.78

ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat Cell Biol (2002) 2.63

An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J (2001) 2.50

Purification of a protein cofactor required for ADP-ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera toxin. J Biol Chem (1984) 2.43

Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature (2006) 2.40

Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci U S A (2004) 2.37

Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev (2012) 2.22

HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors. Cancer Res (2010) 2.11

Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells. J Biol Chem (1991) 1.99

Integrins: the keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol (2008) 1.75

MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7. Curr Biol (2008) 1.55

Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res (2005) 1.52

Requirement for Arf6 in cell adhesion, migration, and cancer cell invasion. J Biochem (2003) 1.50

Arf GAPs as regulators of the actin cytoskeleton. Biol Cell (2007) 1.44

ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway. Cancer Res (2009) 1.40

ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo. Cancer Res (2009) 1.37

The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis. Traffic (2009) 1.31

ARF6-mediated endocytic recycling impacts cell movement, cell division and lipid homeostasis. Semin Cell Dev Biol (2010) 1.30

Molecular mechanisms of resistance to tumour anti-angiogenic strategies. J Oncol (2010) 1.17

Crucial role of the small GTPase ARF6 in hepatic cord formation during liver development. Mol Cell Biol (2006) 1.12

The small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis. Sci Signal (2013) 1.10

A novel GTPase-activating protein for ARF6 directly interacts with clathrin and regulates clathrin-dependent endocytosis. Mol Biol Cell (2005) 1.09

ARF6 in the nervous system. Eur J Cell Biol (2007) 1.06

A RAB5/RAB4 recycling circuitry induces a proteolytic invasive program and promotes tumor dissemination. J Cell Biol (2014) 1.04

Tumor angiogenesis: insights and innovations. J Oncol (2010) 1.04

Clathrin dependent endocytosis of E-cadherin is regulated by the Arf6GAP isoform SMAP1. Exp Cell Res (2007) 1.01

EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling. Cancer Res (2006) 1.01

GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis. PLoS One (2011) 1.00

Docking protein Gab1 is an essential component of postnatal angiogenesis after ischemia via HGF/c-met signaling. Circ Res (2011) 0.98

ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasion. J Cell Biol (2015) 0.98

Novel angiogenesis inhibitors: addressing the issue of redundancy in the angiogenic signaling pathway. Cancer Treat Rev (2011) 0.96

Grp1 plays a key role in linking insulin signaling to glut4 recycling. Dev Cell (2012) 0.96

Inhibition of cell migration by PITENINs: the role of ARF6. Oncogene (2011) 0.87

Angiogenic growth factors in tissue homogenates of HNSCC: expression pattern, prognostic relevance, and interrelationships. Cancer Sci (2009) 0.86

Tissue- and development-dependent expression of the small GTPase Arf6 in mice. Dev Dyn (2010) 0.84

[Arf6, RalA and BIRC5 protein expression in non small cell lung cancer]. Mol Biol (Mosk) (2011) 0.82

GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway. Exp Cell Res (2013) 0.81

Activation machinery of the small GTPase Arf6. Adv Biol Regul (2013) 0.79

Arf6 regulates tumour angiogenesis and growth through HGF-induced endothelial β1 integrin recycling. Nat Commun (2015) 0.79

NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer. Oncogene (2014) 0.77

Increased expression of ARF GTPases in prostate cancer tissue. Springerplus (2015) 0.77

Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma. Oncology (2014) 0.76